This is a past event. Registration is closed. View other China-Italy Chamber of Commerce events.
The seminar is organized by the China-Italy Chamber of Commerce （CICC） together with the EU SME Centre and with the support of Confindustria Lombardia, China IP SME Helpdesk, Assolombarda, ENN Enterprise Europe Network, and Lombardy's Life Sciences Cluster.
The webinar will provide an overview of two main aspects of China's biopharma ecosystem:
- Market and regulations, including: market trends; regulations and market access; the Increasing role of Chinese players; challenges and opportunities for Italian and European companies
- IP rights protection, including: overview of the Chinese law on IP protection for pharmaceuticals; patent and design registration for diagnostic and treatment equipment; preventative measures to minimize the risk of leaking technical secrets; Company and product brand protection
Participation is Free of Charge
Agenda
16:00 – 16:15 Opening remarks
16:15 – 16:45 Overview of China's biopharma ecosystem, Valtero Canepa, Head of China Region, Bracco Group
16:45 – 17:15 Key issues for IP rights protection in China's biopharma sector, XU Jian, China IPR SME Helpdesk expert; Head of IP practice at the China office of Gowling WLG
17:15 – 17:45 Q&A
About the speakers
Valtero Canepa, Head of China Region, Bracco Group.
altero Canepa worked more than 33 years at the Bracco group, where he made his debut as a medical representative, taking on several roles including Global Marketing Director, Country Manager Italy and Project Leader for product development. In 2013 he moved to China, where he is presently responsible for the mainland and Hong Kong business of the Group, including diagnostic contrast agents and medical devices.
He is the present Vice President of the China-Italy Chamber of Commerce (CICC) and he among the founders of the Healthcare Working Group of the CICC.
XU Jian, China IPR SME Helpdesk expert; Head of IP practice at the China office of Gowling WLG
Dr. Jian Xu is a dually qualified Chinese lawyer and patent/trademark attorney. He currently heads up the intellectual property practice at the China office of Gowling WLG.
Dr. Jian Xu joined the firm in 2008 and has been the head of the intellectual property practice of its China office since that date. Prior to that, he was a senior patent attorney at China Sinda, one of the largest intellectual property law firms in Beijing. He has conducted litigation and administrative actions against infringers all over China. He also has a strong background in the chemistry and life science sector, with a bachelor's degree from Beijing and a PhD degree in Biochemistry from the University of Manchester.
